CA
Corriente Advisors Portfolio holdings
AUM
$3.45M
This Quarter Return
+36.1%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$197M
AUM Growth
+$197M
(+28%)
Cap. Flow
+$45.2M
Cap. Flow
% of AUM
22.92%
Top 10 Holdings %
Top 10 Hldgs %
91.19%
Holding
25
New
9
Increased
7
Reduced
–
Closed
9
Top Buys
| 1 |
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
|
$19.6M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$14.9M |
| 3 |
Cue Biopharma
CUE
|
$11.7M |
| 4 |
Cardiff Oncology
CRDF
|
$10.5M |
| 5 |
Beyond Meat
BYND
|
$5.81M |
Top Sells
| 1 |
Sonos
SONO
|
$23M |
| 2 |
uniQure
QURE
|
$8.11M |
| 3 |
Ocular Therapeutix
OCUL
|
$6M |
| 4 |
Celldex Therapeutics
CLDX
|
$5.98M |
| 5 |
Tesla
TSLA
|
$2.16M |
Sector Composition
| 1 | Healthcare | 51.92% |
| 2 | Technology | 27.01% |
| 3 | Consumer Staples | 5.14% |
| 4 | Industrials | 2.44% |
| 5 | Communication Services | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $49.2M | 24.94% | 1,972,061 +72,061 | +4% | +$1.8M |
|
|
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $29.2M | 14.82% | 300,000 +152,500 | +103% | +$14.9M |
|
|
3
Cue Biopharma
CUE
$60M
| $21.6M | 10.97% | 1,437,445 +777,458 | +118% | +$11.7M |
|
|
APTO
4
DELISTED
Aptose Biosciences, Inc.
APTO
| $20.6M | 10.44% | 3,430,000 +658,688 | +24% | +$3.95M |
|
|
TFFP
5
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $19.6M | 9.92% | +1,058,823 | New | +$19.6M |
|
|
6
Cardiff Oncology
CRDF
$140M
| $12.9M | 6.55% | 910,000 +736,639 | +425% | +$10.5M |
|
7
Replimune Group
REPL
$422M
| $11.8M | 5.98% | 512,500 +27,500 | +6% | +$633K |
|
|
8
Beyond Meat
BYND
$192M
| $5.81M | 2.95% | +35,000 | New | +$5.81M |
|
9
Virgin Galactic
SPCE
$179M
| $4.81M | 2.44% | +250,000 | New | +$4.81M |
|
10
Village Farms International
VFF
$368M
| $4.32M | 2.19% | +943,396 | New | +$4.32M |
|
11
Datadog
DDOG
$47.7B
| $4.09M | 2.07% | +40,000 | New | +$4.09M |
|
|
SIOX
12
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $4.04M | 2.05% | +875,000 | New | +$4.04M |
|
13
Roku
ROKU
$14.2B
| $3.78M | 1.91% | +20,000 | New | +$3.78M |
|
14
DiaMedica Therapeutics
DMAC
$295M
| $3.1M | 1.57% | 730,000 +528,752 | +263% | +$2.24M |
|
|
CMRX
15
DELISTED
Chimerix, Inc.
CMRX
| $122K | 0.06% | +49,085 | New | +$122K |
|
16
Arrowhead Research
ARWR
$3.05B
| – | – | -40,000 | Closed | -$1.73M |
|
|
17
Celldex Therapeutics
CLDX
$1.47B
| – | – | -460,000 | Closed | -$5.98M |
|
|
18
Ocular Therapeutix
OCUL
$2.12B
| – | – | -720,000 | Closed | -$6M |
|
19
Pan American Silver
PAAS
$12.3B
| – | – | -30,000 | Closed | -$912K |
|
|
20
uniQure
QURE
$896M
| – | – | -180,000 | Closed | -$8.11M |
|
|
RWT
21
Redwood Trust
RWT
$791M
| – | – | -75,000 | Closed | -$525K |
|
|
22
Sonos
SONO
$1.68B
| – | – | -1,570,000 | Closed | -$23M |
|
|
23
Tesla
TSLA
$1.08T
| – | – | -2,000 | Closed | -$2.16M |
|
|
PVLA
24
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| – | – | -270,000 | Closed | -$837K |
|